Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib with Cisplatin and Gemcitabine in Advanced Urothelial Carcinoma
NCT01089088Phase 2Completed
- Sponsor
- Cardiff University
- Start
- Apr 2009
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in transitional cell carcinoma of the urothelium (TCC), sponsored by Cardiff University. Started Apr 2009; status: completed.
02
Drugs
sunitinib
03
Conditions
transitional cell carcinoma of the urothelium (TCC)
Beyond the preview
Go deeper on NCT01089088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01089088.